Keppel says “asset-light,” headlines say “S$385M unlocked”—but profit still fell. That’s your first red flag. This episode breaks down why selling assets feels good short term but can quietly weaken your dividend engine. Think of it like selling your HDB rental income to run a kopi franchise—nice fees, but can it match daily cash flow? If you’re relying on Keppel for steady retirement income, this transition matters more than the headlines.
Key takeaways:
Asset sales boost cash now, but don’t equal recurring income
13% fee growth still too small to replace real estate earnings
S$7.6B contracts ≠ guaranteed distributable cash flow
Dividend risk rises if monetisation slows or assets run out
Watch LP commitments and S$2–3B sales target closely
CTA: Full forensic breakdown on Substack, early alerts on Telegram
Iggy’s Forensic Disclaimer
This content is produced for educational and informational purposes only. I am not a financial advisor — I am a retail investor who applies forensic analysis to my own portfolio and shares that process publicly. Nothing here constitutes a recommendation to buy, sell, or hold any security, and no specific target prices or personalised financial advice are offered. Stocks assessed under Iggy’s Forensic Yield Standard are benchmarked against a 4.7% minimum yield hurdle; stocks flagged as Growth Watch fall below this threshold but demonstrate clean balance sheet metrics and an identifiable growth catalyst — these carry a materially different risk profile and are not suitable as yield replacements for income-dependent investors. All data is sourced from public filings and verified sources; where data is unverified it is explicitly flagged. All investments carry risk, including the potential loss of principal, and past performance is not indicative of future results. If you are making investment decisions involving CPF, SRS, or personal capital, please conduct your own due diligence or consult a MAS-licensed financial adviser before committing funds.
